Oral Vancomycin Prophylaxis for Clostridioides difficile in High-Risk Patients Receiving Systemic Antibiotics: What Exactly Are We Preventing?

Clin Infect Dis. 2020 Oct 23;71(7):1798. doi: 10.1093/cid/ciz1216.

Authors

Randy McCreery¹, Kelly Cawcutt¹, Nicolas Cortes-Penfield¹, Trevor Van Schooneveld¹

Affiliation

¹ Section of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

PMID: 32052036
DOI: 10.1093/cid/ciz1216

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use
Clostridioides
Clostridium Infections* / drug therapy
Clostridium Infections* / prevention & control
Delivery of Health Care
Humans
Vancomycin* / therapeutic use

Substances

Anti-Bacterial Agents
Vancomycin